Drug Induced Liver Disease (Hepatotoxicity)-References

1). Carol Simmons. “Beware: Antibiotic-Induced Hepatotoxicity is Rare but Deadly”.      Hospital Pharmacy Volume 37, Number 3.2002: PP 326–330.

2). Kaplowitz Neli and Deleve D. Laurie. “Liver Disease”. Informa Healthcare, New York, USA. 2007: 2^nd Edition. PP.4-6, 13-22, 27. ISBN-13: 978-0-8493-9896-4.

3). Michael P. Holt  and Cynthia Ju. “Mechanisms of Drug-Induced Liver Injury”. The AAPS Journal. 2006: PP.E48-E52.

4). Navarro J. Victor and Senior R. John. “Drug-Related Hepatotoxicity”. N Engl J Med.2006: PP.354,731-739.

5). Ramachandran R and Kakar S. “Histological patterns in drug-induced liver disease”.  BMJ. 2008: PP.481-489.

6). Reilly TP , Brady JN , Marchick MR , et al . A protective role for cyclooxygenase-2 in drug-induced liver injury in mice. Chem Res Toxicol . 2001: 14, 1620 - 1628.

7). Stefan Russmann, Gerd A. Kullak-Ublick and Ignazio Grattagliano. “Current  Concepts of Mechanisms in Drug-Induced Hepatotoxicity”. Current Medicinal Chemistry. Bentham Science Publishers Ltd..2009: PP.16, 3041-3053.

8). Tsutsui H , Matsui K , Kawada N , et al . “IL-18 accounts for both TNFalpha- and Fas ligand-mediated hepatotoxic pathways in endotoxininduced liver injury in mice”. J Immunol. 1997: 159, 3961 - 3967 .

9). Watkins PB, Whitcomb RW. “Hepatic dysfunction associated with troglitazone”. N Engl J Med. 1998: 338,916-7.

10). William M. Lee. “Drug-Induced Hepatotoxicity”. N Engl J Med. 2003:PP.349:474-85.